Hochschulschrift
Fc-optimized antibodies for the treatment of B-cell acute lymphoblastic leukemia and colorectal cancer
- Sprache
-
Englisch
- Umfang
-
72 Seiten, 34 verschieden gezählte Seiten
- Maße
-
21 cm
- Anmerkungen
-
Illustrationen, Diagramme
Enthält Sonderabdrucke
Eberhard Karls Universität Tübingen, Dissertation, 2020
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Urheber
- Beteiligte Personen und Organisationen
- Ereignis
-
Veröffentlichung
- (wo)
-
Tübingen
- (wann)
-
2020
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 11:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Entstanden
- 2020
Ähnliche Objekte (12)
On the hunt for B-cell lymphoblastic leukemia-initiating stem cells
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
LncRNAs signature defining major subtypes of B-cell acute lymphoblastic leukemia
Cyclin D3 is essential for the maintenance of B-cell acute lymphoblastic leukemia
Immunotherapy of pediatric acute lymphoblastic B-cell leukemia using gene-modified T cells
Impact of mesenchymal stromal cell-derived vesicular cargo on B-cell acute lymphoblastic leukemia progression
The clinical relevance of aneuploidy in relapses of pediatric B-cell precursor acute lymphoblastic leukemia
Impact of mesenchymal stromal cell–derived vesicular cargo on B-cell acute lymphoblastic leukemia progression
Development of bispecific antibodies with optimized T cell costimulatory activity
Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
BAFF/APRIL system is functional in B-cell acute lymphoblastic leukemia in a disease subtype manner
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
On the hunt for B-cell lymphoblastic leukemia-initiating stem cells
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
LncRNAs signature defining major subtypes of B-cell acute lymphoblastic leukemia
Cyclin D3 is essential for the maintenance of B-cell acute lymphoblastic leukemia
Immunotherapy of pediatric acute lymphoblastic B-cell leukemia using gene-modified T cells
Impact of mesenchymal stromal cell-derived vesicular cargo on B-cell acute lymphoblastic leukemia progression
The clinical relevance of aneuploidy in relapses of pediatric B-cell precursor acute lymphoblastic leukemia
Impact of mesenchymal stromal cell–derived vesicular cargo on B-cell acute lymphoblastic leukemia progression
Development of bispecific antibodies with optimized T cell costimulatory activity
Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
BAFF/APRIL system is functional in B-cell acute lymphoblastic leukemia in a disease subtype manner
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
On the hunt for B-cell lymphoblastic leukemia-initiating stem cells
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
LncRNAs signature defining major subtypes of B-cell acute lymphoblastic leukemia
Cyclin D3 is essential for the maintenance of B-cell acute lymphoblastic leukemia
Immunotherapy of pediatric acute lymphoblastic B-cell leukemia using gene-modified T cells
Impact of mesenchymal stromal cell-derived vesicular cargo on B-cell acute lymphoblastic leukemia progression
The clinical relevance of aneuploidy in relapses of pediatric B-cell precursor acute lymphoblastic leukemia
Impact of mesenchymal stromal cell–derived vesicular cargo on B-cell acute lymphoblastic leukemia progression
Development of bispecific antibodies with optimized T cell costimulatory activity
Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
BAFF/APRIL system is functional in B-cell acute lymphoblastic leukemia in a disease subtype manner